Nuwellis (NUWE) Change in Receivables (2011 - 2026)
Nuwellis' (NUWE) quarterly Change in Receivables came in at -$14000.0 in Q2 2026, up 95.97% on a YoY basis from -$7144.1 in Q2 2025, and down 121.21% quarter-over-quarter from $66000.0 in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Change in Receivables (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Change in Receivables for 13 consecutive years, with -$14000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 95.97% year-over-year to -$14000.0; the trailing twelve-month figure through Jun 2026 stood at $352000.0 (up 455.56% YoY), and the FY2025 full-year result was -$234000.0, down 4.46% from the prior year.
- Change in Receivables eased to -$14000.0 in Q2 2026 per NUWE's latest filing, from $66000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $526000.0 in Q4 2023 and bottomed at -$725000.0 in Q1 2024.
- Historically, Change in Receivables has averaged $44166.7 across 5 years, with a median of $33500.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 1335.71% in 2022, then sank 5300.0% in 2025.
- Over 5 years, Change in Receivables stood at $306000.0 in 2022, then soared by 71.9% to $526000.0 in 2023, then declined by 17.49% to $434000.0 in 2024, then slipped by 18.89% to $352000.0 in 2025, then plunged by 103.98% to -$14000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$14000.0, $66000.0, and $352000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -14,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,000.00 |
| Mar 31, 2026 | 66,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | -52,000.00 |
| Jun 30, 2025 | -347,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | -725,000.00 |
| Dec 31, 2023 | 526,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Jun 30, 2023 | -125,000.00 |
| Mar 31, 2023 | -105,000.00 |
| Dec 31, 2022 | 306,000.00 |
| Sep 30, 2022 | -213,000.00 |
| Jun 30, 2022 | 362,000.00 |
| Mar 31, 2022 | 201,000.00 |
| Dec 31, 2021 | -319,000.00 |
| Sep 30, 2021 | -108,000.00 |